Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: lavalamp who wrote (10144)	10/25/1997 10:22:00 PM
From: james	Read Replies (1) \| Respond to of 32384

Good question, lavalamp. 1. I bought 500 shrs of Sun Micro last Thursday for $37. Just few bucks away from a penny. 2. Mice tests are standard. Disease modelling is the key. db/db & ob/ob mice, people commonly used for type II modelling, are early onset. Quite different from human type II-----late onset, 80% of the patient population. But there is no alternatives, & that is the risk to predict type II drugs for everybody. NOT JUST LGND. 3. I joined this Co., & is doing research now, which is also light year away from LGND's success.